Condition: Metastatic Malignant Neoplasm in the Brain · Metastatic Malignant Solid Neoplasm · Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
This phase II trial studies the neurological function in patients with multiple brain metastases undergoing stereotactic radiosurgery (SRS) or stereotactic body radiation therapy (SBRT). Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Assessment of neurocognitive function may help show that SRS preserves neurological function in patients with multiple brain metastases better than SBRT.
This description comes directly from the study's public registry record.
Wenyin Shi, MD · (215) 955-6702 · wenyin.shi@jefferson.edu
Always discuss trial participation with your own doctor first.
| Jefferson Health New Jersey | Sewell, New Jersey, United States | Not Yet Recruiting |
| Sidney Kimmel Cancer Center at Thomas Jefferson University | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03184038